Status:
COMPLETED
Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Endstage Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
Patients undergoing chronic dialysis are at a substantially increased risk of cardiac death. The reasons for this excess cardiovascular mortality are only partly understood. Classical complicated arth...
Detailed Description
Eligible patients will be identified through the clinical care team by undergoing chronic dialysis at one of the study centres. Dialysis patients will be initially approached during a routine dialysis...
Eligibility Criteria
Inclusion
- \- Age ≥18 years
- Initiation of chronic hemodialysis or currently undergoing chronic hemodialysis at one of the study centres
- Initiation of chronic peritoneal dialysis or currently undergoing chronic peritoneal dialysis at one of the study centres
- Written informed consent
Exclusion
- Age \< 18 years
- No written informed consent
Key Trial Info
Start Date :
December 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT02207153
Start Date
December 1 2016
End Date
August 1 2018
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031